| pubmed-article:15212156 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C0033215 | lld:lifeskim |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:15212156 | lifeskim:mentions | umls-concept:C0014020 | lld:lifeskim |
| pubmed-article:15212156 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15212156 | pubmed:dateCreated | 2004-6-23 | lld:pubmed |
| pubmed-article:15212156 | pubmed:abstractText | Galactosylated emulsions containing cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)amino)butyl)formamide (Gal-C4-Chol) as a "homing device" were developed for hepatocyte-selective drug targeting. The targeting efficiency of galactosylated emulsions was evaluated by a distribution study in mice. | lld:pubmed |
| pubmed-article:15212156 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15212156 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15212156 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15212156 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15212156 | pubmed:issn | 0724-8741 | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:NishikawaMaki... | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:YamashitaFumi... | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:HashidaMitsur... | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:KawakamiShige... | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:ManagitChitti... | lld:pubmed |
| pubmed-article:15212156 | pubmed:author | pubmed-author:IshidaEmiE | lld:pubmed |
| pubmed-article:15212156 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15212156 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:15212156 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15212156 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15212156 | pubmed:pagination | 932-9 | lld:pubmed |
| pubmed-article:15212156 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:meshHeading | pubmed-meshheading:15212156... | lld:pubmed |
| pubmed-article:15212156 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15212156 | pubmed:articleTitle | Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. | lld:pubmed |
| pubmed-article:15212156 | pubmed:affiliation | Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. | lld:pubmed |
| pubmed-article:15212156 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15212156 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15212156 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
